why choose us

Clinical Trials Search

Showing 13,610 of 132,366 result(s)
A Study to Understand the Safety and Effects of New Formulations of a Clostridioides Difficile Vaccine Shot That Will be Given to Healthy Adults

Status: ACTIVE_NOT_RECRUITING

Condition: Clostridoides Difficile Associated Disease

Interventions: Toxoid based Clostridioides difficile vaccine (previously studied formulation) given as an intramuscular injection

Date: 2023-03-21

A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

Status: Completed

Condition: Biochemically Recurrent Prostate Cancer

Interventions: Coated tablet, 300 mg ; tablet, oral.

Date: 2023-03-21

Treatment of Gingival Recession Defects Using Platelet-Rich Fibrin With an Allogenic Dermal Matrix

Status: ACTIVE_NOT_RECRUITING

Condition: Gingival Recession

Interventions: Describes the flap design for both treatment arms

Date: 2023-03-21

Effectiveness of Motivation Skills Training (MST)

Status: NOT_YET_RECRUITING

Condition: Schizophrenia

Interventions: Participants will complete a baseline assessment, receive weekly MST sessions in a group format for a duration of 12 weeks, and will then repeat the a

Date: 2023-03-21

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

Status: Completed

Condition: Non-muscle-invasive Bladder Cancer

Interventions: Cystoscopy entails direct inspection of the bladder via a cystoscope that is inserted into a patient's urethra.

Date: 2023-03-21

Effects of Early Time Restricted Eating on Muscle Performance in Resistance Trained Individuals

Status: Completed

Condition: Time Restricted Eating

Interventions: The intervention group will eat in a prescribed daily feeding window (9am-5pm) and follow their normal exercise and resistance training routines.

Date: 2023-03-21

Epileptic Hippocampus in Alzheimer's Disease

Status: NOT_YET_RECRUITING

Condition: Alzheimer Disease

Interventions:

  • Intravenous administration: 25 mg or 50 mg will be administered depending on its effects on epileptic activity during a hospital stay where si

    Date: 2023-03-21

Education and Counseling Program Based on the Health Promotion Model

Status: COMPLETED

Condition: Urinary Incontinence

Interventions:

The women included in the second stage were given a pre-test before the training program.
Training program included behavioral and lifestyle c

Date: 2023-03-21

Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia

Status: Completed

Condition: Neurofibroma

Interventions:

Date: 2023-03-21

Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder

Status: Completed

Condition: Tobacco Use

Interventions: IM ketamine given in weekly session for a total of 3 weeks

Date: 2023-03-21